| |
Thanks Mark!
As always, your efforts are greatly appreciated!
>> For most of us it does not seem like things are happening fast enough - and I feel the same way. <<
I am not trying to flippant when I say - I don't. Having witnessed a similar process with CCSI and CALY, the pace of DMX.T seems right to me.
>> I suspect that they may be considering some sort of capital acquisition and they want the flexibility to move fast if need be. <<
I also suspect that flexibility to move fast will be needed to begin marketing Pennsaid, not to mention WF-10.
>> they are exploring a NASDAQ listing <<
Nice to know this matter is no longer just something Peter mentions hypothetically over the phone!
>> Company Structure - for operational purposes, the company now basically has 2 boards. The first consists of members whose primary responsibility is the "business" of the company. The second board consists of members whose primary responsibility is the "science" of the company. <<
Is this a recent development, or has it been this way for a while. I must confess I never asked about this in the past.
>> Dimethaid has decided, rather than the company releasing the data, they are allowing the research group first crack at publishing the outcome in a peer reviewed journal. <<
I just love the shrewdness of these folks!!!
>> momentum players leaving the stock temporarily .... rest assured they will be back. Frankly, I think the stock acted very nicely today .... it is still well above its 50 day SMA ...... there were a lot of buyers. <<
Totaly agree. Like you, I was one of the buyers today, and will be on future weakness.
Bounced Czech
(Never felt more positive about this puppy!) |
|
